What is Pacemate?
Founded in 2015 and headquartered in Florida, PaceMate operates at the intersection of healthcare and technology, focusing on providing robust solutions for managing cardiac data compliantly. The company's expertise in this niche area positions it as a key player in a market increasingly reliant on secure and efficient data handling for patient care and regulatory adherence. The recent major enterprise-level funding suggests a phase of significant scaling and market expansion for the company.
How much funding has Pacemate raised?
Pacemate has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2021): $8M with participation from Ballast Point Ventures LP
Key Investors in Pacemate
Ballast Point Ventures LP
Ballast Point Ventures LP is an investment firm that typically backs companies in various stages of growth, likely focusing on sectors with strong market potential.
What's next for Pacemate?
With the recent influx of capital, PaceMate is poised for accelerated growth and further development of its compliant cardiac data management platform. The enterprise-level backing indicates confidence from investors in the company's business model and its potential to capture a larger share of the digital healthcare market. Future strategic initiatives are likely to focus on expanding its service offerings, enhancing technological capabilities, and potentially broadening its geographical reach. This investment will be crucial for PaceMate to solidify its competitive advantage and drive innovation in cardiac data solutions.
See full Pacemate company page
